Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
112,318,617
-
Total 13F shares
-
135,659,696
-
Share change
-
+4,590,522
-
Total reported value
-
$1,147,817,881
-
Put/Call ratio
-
54%
-
Price per share
-
$8.46
-
Number of holders
-
237
-
Value change
-
+$12,305,118
-
Number of buys
-
120
-
Number of sells
-
112
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q3 2025
As of 30 Sep 2025,
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by
237 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,659,696 shares.
The largest 10 holders included
CADIAN CAPITAL MANAGEMENT, LP, VANGUARD GROUP INC, BlackRock, Inc., FMR LLC, MORGAN STANLEY, EVENTIDE ASSET MANAGEMENT, LLC, Rubicon Founders LLC, Engaged Capital LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and JPMORGAN CHASE & CO.
This page lists
237
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.